We are live on
!
Find out more
Iovance Biotherapeutics
IOVA
IOVA
126 hedge funds and large institutions have $1.07B invested in Iovance Biotherapeutics in 2018 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 53 increasing their positions, 34 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
137% more call options, than puts
Call options by funds: $4.65M | Put options by funds: $1.96M
56% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 34
32% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 19
5.92% more ownership
Funds ownership: 86.94% → 92.86% (+5.9%)
3% more funds holding
Funds holding: 122 → 126 (+4)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
19% less capital invested
Capital invested by funds: $1.31B → $1.07B (-$247M)
Holders
126
Holders Change
+4
Holders Change %
+3.28%
% of All Funds
2.88%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.18%
New
25
Increased
53
Reduced
34
Closed
19
Calls
$4.65M
Puts
$1.96M
Net Calls
+$2.69M
Net Calls Change
-$3.45M
Top Buyers
| 1 |
BC
Broadfin Capital
New York
|
+$47.3M |
| 2 |
State Street
Boston,
Massachusetts
|
+$24.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$22.6M |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$12.1M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$7.75M |
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$54.2M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$16.7M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$9.35M |
| 4 |
QF
QVT Financial
New York
|
-$8.63M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$6.14M |
